Discovery of SARS-CoV-2–induced pathways uncovers groundbreaking drug repurposing strategies

By | July 7, 2021
A new study has been published in Science Advances that exploits proteomics datasets to develop an agnostic network for SARS-CoV-2–induced pathways, thereby unveiling novel targets and potential repurposing strategies.